Alk-Abello AS (AKBLF)
22.05
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Alk-Abello Total Liabilities (Quarterly): 309.00M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 309.00M |
| June 30, 2024 | 305.19M |
| March 31, 2024 | 302.91M |
| December 31, 2023 | 338.37M |
| September 30, 2023 | 315.41M |
| June 30, 2023 | 331.70M |
| March 31, 2023 | 327.61M |
| December 31, 2022 | 333.91M |
| September 30, 2022 | 308.49M |
| June 30, 2022 | 339.90M |
| March 31, 2022 | 346.80M |
| December 31, 2021 | 357.75M |
| September 30, 2021 | 375.05M |
| June 30, 2021 | 372.23M |
| March 31, 2021 | 388.06M |
| December 31, 2020 | 398.34M |
| September 30, 2020 | 373.69M |
| June 30, 2020 | 368.09M |
| March 31, 2020 | 348.54M |
| December 31, 2019 | 347.67M |
| September 30, 2019 | 278.13M |
| June 30, 2019 | 296.61M |
| March 31, 2019 | 291.09M |
| December 31, 2018 | 258.28M |
| September 30, 2018 | 244.59M |
| Date | Value |
|---|---|
| June 30, 2018 | 254.24M |
| March 31, 2018 | 270.30M |
| December 31, 2017 | 268.80M |
| September 30, 2017 | 276.04M |
| June 30, 2017 | 276.43M |
| March 31, 2017 | 287.30M |
| December 31, 2016 | 273.61M |
| September 30, 2016 | 253.89M |
| June 30, 2016 | 248.35M |
| March 31, 2016 | 252.54M |
| December 31, 2015 | 227.78M |
| September 30, 2015 | 221.43M |
| June 30, 2015 | 214.07M |
| March 31, 2015 | 163.96M |
| December 31, 2014 | 173.88M |
| September 30, 2014 | 173.70M |
| June 30, 2014 | 186.61M |
| March 31, 2014 | 193.70M |
| December 31, 2013 | 188.61M |
| September 30, 2013 | 180.75M |
| June 30, 2013 | 174.73M |
| March 31, 2013 | 177.54M |
| December 31, 2012 | 183.98M |
| September 30, 2012 | 165.19M |
| June 30, 2012 | 155.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
302.91M
Minimum
Mar 2024
398.34M
Maximum
Dec 2020
344.43M
Average
343.35M
Median
Total Liabilities (Quarterly) Benchmarks
| Genmab AS | 1.159B |
| Ascendis Pharma AS | 1.330B |
| Galecto Inc | 2.441M |
| Evaxion Biotech AS | 15.18M |
| IO Biotech Inc | 17.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.071B |
| Shareholders Equity (Quarterly) | 761.79M |
| Debt to Equity Ratio | 0.0372 |
| Current Ratio | 2.950 |
| Net Debt Paydown Yield | 0.13% |